Sign in

CIK 0001818382

  • Non-accelerated filer
  • Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851763759
Phone
+1 919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale President, CEO and Director sold 500,000 shares at $3.12 ($1,558,750)
  9. 4 Open-market sale Director sold 500,000 shares at $3.12 ($1,558,750)
  10. 4 Open-market sale 10% owner sold 500,000 shares at $3.12 ($1,558,750)
  11. 4 Open-market sale President, CEO and Director sold 4,875,000 shares at $2.60 ($12,675,000)
  12. 4 Open-market sale Director sold 4,875,000 shares at $2.60 ($12,675,000)
  13. 4 Open-market sale 10% owner sold 4,875,000 shares at $2.60 ($12,675,000)
  14. 4 Open-market sale President, CEO and Director sold 2,625,000 shares at $2.75 ($7,218,750)
  15. 4 Open-market sale Chief Operating Officer sold 23,402 shares at an average $4.01 ($93,904)
  16. 4 Open-market sale Director sold 2,625,000 shares at $2.75 ($7,218,750)
  17. 4 Open-market sale 10% owner sold 2,625,000 shares at $2.75 ($7,218,750)
  18. 4 Open-market buy Director bought 4,750 shares at $4.18 ($19,855)
  19. 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
  20. 4 Exercise or conversion President, CEO and Director acquired 100,000 shares (option exercise)

Page 7 of 12 · 235 filings